🔥New @amjtransplant: we found that #EVLP was associated w/ similar 🫁 txp outcomes, but ⬆️ pt care costs compared to cold storage.
🔑 point: despite ⬆️ cost, EVLP was profitable for our center & remains a promising strategy to ⬆️ the 🫁 donor pool
https://t.co/s530spUhYL
Featured article in @JSurgRes. Vascularized Composite Allotransplantation: A Functional Hind Limb Model in Mice. Many thanks to Dr. Cendales. @DukeSurgery@Duke_GATORs@DukeSurgRes https://t.co/DtdxoiXLnC
Here is our recent publication on the effect of the pandemic on journalistic practices. Many thanks to my mentor and Chair, Dr. Allan D. Kirk @DukeSurgRes@DukeSurgery@Duke_GATORs Covid-19 and the evolution of scientific publishing -https://t.co/Vip8xiWd6M
Congratulations to Dr. Qimeng Gao, MD, General Surgery Resident, on receiving an @ASTSChimera 2021 Jon Fryer Resident Scientist Scholarship for his research on gene therapy in solid organ transplant with the help of Dr. Sam Kesseli.
New paper in @BJSurgery by the COVIDSurg Collaborative (including @Duke_GATORs@drewbarbz & Dimitrios Moris) analyzes the number needed to vaccinate among surgical patients to save lives!
https://t.co/HB1YF8flCY
.@SJKesseli et al. conclude that preoperative embolization is an effective modality to mitigate exsanguinating blood loss during multivisceral #transplant in patients with portomesenteric thrombosis. https://t.co/PHqiBNsXT0
⭐️Listing for kidney txp within 1 year of liver txp increased from 2.9% to 8.8% post-policy
⭐️Rate of kidney txp within 1 year post liver txp - 0.7% to 4%.
⭐️No difference in patient survival between SLK and LT alone with ESRD
Background: SLK criteria changed in 2017 and implemented a safety net policy for kidney after liver txp.
❓What were the impacts of this policy among GFR<25?
Results:
⭐️Fewer pts with GFR>30 underwent SLK
⭐️Less variability in GFR at txp